Skip to content

Effect of Intraoperative Anesthetic Management on Postoperative Nausea and Vomiting in Bariatric Surgery

Effect of Intraoperative Anesthetic Management on Postoperative Nausea and Vomiting (PONV) in Bariatric Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01449708
Enrollment
124
Registered
2011-10-10
Start date
2011-11-30
Completion date
2012-10-31
Last updated
2016-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Nausea and Vomiting

Keywords

Bariatric Surgery, TIVA, PONV, non-opioid, OSA

Brief summary

Morbidly obese patients are at high risk for Postoperative Nausea and Vomiting (PONV) after surgery and general anesthesia. The results of our observational study indicate that 42.7% of patients require medication to treat PONV in the first 24 hours after bariatric surgery despite our aggressive perioperative approach with triple prophylaxis. Common risk factors for PONV are the use of intraoperative narcotics and anesthetic gases. Preliminary results of multimodal postoperative analgesia in the first 24 hours lead to a reduction of narcotic consumption, desaturations and use of antiemetic medication. Our study hypothesis is that different types of anesthetics reduce PONV further. Patient would be randomly assigned to receive either our current intraoperative management or a narcotic free, total intravenous general anesthetic (TIVA). The investigators hope to improve patients' satisfaction by reducing PONV in the postoperative period.

Detailed description

See above

Interventions

DRUGTIVA NoNarc

* patients in both groups receive antiemetic prophylaxis * patients in the TIVA NoNarc group will receive propofol, dexmedetomidine, ketamine, ketorolac and acetaminophen intraoperatively * postop management in both groups is similar in both groups

Sponsors

Coastal Anesthesiology Consultants
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients scheduled for bariatric surgery at Flagler Hospital will be included after written and informed consent.

Exclusion criteria

* Patients will be excluded from the study if they don't consent to participate in the study. Patients allergic to any of the study medication will be excluded. Patients with second or third degree heart block will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
PONV During the First 24 Hours After Bariatric Surgery24 hoursPostoperative Nausea and Vomiting

Secondary

MeasureTime frame
Number of Patients Requiring Antiemetic Rescue Medication (AERM)24hours
PONV Between Different Surgical Procedures (Percentage of Participants)24 hours

Countries

United States

Participant flow

Participants by arm

ArmCount
Classic/Balanced Anesthesia
Patients will receive balanced general anesthesia including volatile anesthetics and narcotics. This reflects our current clinical practice. * patients in both groups receive antiemetic prophylaxis * postop management in both groups is similar in both groups
59
TIVA
* patients in both groups receive antiemetic prophylaxis * patients in the TIVA NoNarc group will receive propofol, dexmedetomidine, ketamine, ketorolac and acetaminophen intraoperatively * postop management in both groups is similar in both groups
60
Total119

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyProtocol Violation01
Overall Studyrespiratory failure10
Overall Studysurgical complication12

Baseline characteristics

CharacteristicClassic/Balanced AnesthesiaTIVATotal
Age, Continuous50.4 years
STANDARD_DEVIATION 3.2
50.5 years
STANDARD_DEVIATION 3.5
50.4 years
STANDARD_DEVIATION 2.4
Region of Enrollment
United States
59 participants60 participants119 participants
Sex: Female, Male
Female
43 Participants39 Participants82 Participants
Sex: Female, Male
Male
16 Participants21 Participants37 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 590 / 60
serious
Total, serious adverse events
0 / 590 / 60

Outcome results

Primary

PONV During the First 24 Hours After Bariatric Surgery

Postoperative Nausea and Vomiting

Time frame: 24 hours

ArmMeasureValue (NUMBER)
Classic / Balanced AnesthesiaPONV During the First 24 Hours After Bariatric Surgery22 participants
TIVAPONV During the First 24 Hours After Bariatric Surgery12 participants
p-value: 0.0495% CI: [1.01, 1.61]Chi-squared
Secondary

Number of Patients Requiring Antiemetic Rescue Medication (AERM)

Time frame: 24hours

ArmMeasureValue (NUMBER)
Classic / Balanced AnesthesiaNumber of Patients Requiring Antiemetic Rescue Medication (AERM)26 participants
TIVANumber of Patients Requiring Antiemetic Rescue Medication (AERM)17 participants
Secondary

PONV Between Different Surgical Procedures (Percentage of Participants)

Time frame: 24 hours

Population: analysis was conducted with all participants and NOT per arm

ArmMeasureGroupValue (NUMBER)
Classic / Balanced AnesthesiaPONV Between Different Surgical Procedures (Percentage of Participants)Sleeve Gastrectomy58.6 percentage of participants
Classic / Balanced AnesthesiaPONV Between Different Surgical Procedures (Percentage of Participants)Gastric Bypass (LRYGB)19.4 percentage of participants
Classic / Balanced AnesthesiaPONV Between Different Surgical Procedures (Percentage of Participants)Gastric Band0 percentage of participants
Classic / Balanced AnesthesiaPONV Between Different Surgical Procedures (Percentage of Participants)revision LRYGB23.1 percentage of participants
Classic / Balanced AnesthesiaPONV Between Different Surgical Procedures (Percentage of Participants)Conversion to LRYGB0 percentage of participants
Comparison: Grouping of surgical procedures into three categories, analysis using bonferroni correction, 1) ReY group( gastric bypass, conversion to gastric bypass and revision gastric bypass) 2) Gastric Band (GB), 3) sleeve gastrectomy (SG)p-value: 0.00995% CI: [1.28, 7.29]Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026